PF-Atlas › Clinical Trials › NCT06777368

REdo tranScatheter Aortic Valve Replacement for Transcatheter aOrtic Valve failuRE

Medtronic TAV · Not specified

Registry ID

NCT06777368

Phase

Not specified

Status

Recruiting

Drug / intervention

Medtronic TAV

Sponsor

Medtronic Cardiovascular

Start

2025-02-06

Enrollment

225

Locations

About this trial

The purpose of this study is to generate clinical evidence on valve safety and performance in subjects treated by redo Transcatheter Aortic Valve Replacement (TAVR).

View NCT06777368 on ClinicalTrials.gov →

Explore related

All Medtronic TAV trials All IPF trials

Medical disclaimer. This page summarizes public trial data for NCT06777368 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.